| 持有 万泰生物(603392)的基金 |
| 报告期：2022-12-31 |
| 序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
| 1 | 161726 | 招商国证生物医药指数分级 | 507,114,216.00 | 4,002,480.00 | 3.56 |
| 2 | 512170 | 华宝中证医疗ETF | 376,831,773.50 | 2,974,205.00 | 2.16 |
| 3 | 000960 | 招商医药健康产业股票 | 220,339,915.60 | 1,739,068.00 | 7.55 |
| 4 | 009275 | 融通医疗保健行业混合C | 101,360,000.00 | 800,000.00 | 6.55 |
| 5 | 161616 | 融通医疗保健行业混合A | 101,360,000.00 | 800,000.00 | 6.55 |
| 6 | 003230 | 创金合信医疗保健股票A | 93,799,937.70 | 740,331.00 | 8.77 |
| 7 | 003231 | 创金合信医疗保健股票C | 93,799,937.70 | 740,331.00 | 8.77 |
| 8 | 009360 | 招商创新增长混合A | 49,517,780.90 | 390,827.00 | 7.16 |
| 9 | 009361 | 招商创新增长混合C | 49,517,780.90 | 390,827.00 | 7.16 |
| 10 | 009881 | 广发中证医疗指数(LOF)C | 42,028,290.50 | 331,715.00 | 2.09 |
| 11 | 502056 | 广发中证医疗指数(LOF)A | 42,028,290.50 | 331,715.00 | 2.09 |
| 12 | 010586 | 创金合信医药消费股票C | 33,883,381.00 | 267,430.00 | 8.22 |
| 13 | 010585 | 创金合信医药消费股票A | 33,883,381.00 | 267,430.00 | 8.22 |
| 14 | 320021 | 诺安双利债券发起式 | 30,226,692.30 | 238,569.00 | 1.22 |
| 15 | 310318 | 申万菱信沪深300指数增强A | 23,188,000.50 | 183,015.00 | 1.83 |
| 16 | 007804 | 申万菱信沪深300指数增强C | 23,188,000.50 | 183,015.00 | 1.83 |
| 17 | 161122 | 易方达生物科技指数分级 | 22,261,696.80 | 175,704.00 | 2.17 |
| 18 | 009778 | 长信消费升级混合A | 15,160,922.00 | 119,660.00 | 5.08 |
| 19 | 009779 | 长信消费升级混合C | 15,160,922.00 | 119,660.00 | 5.08 |
| 20 | 163001 | 长信医疗保健混合(LOF) | 12,520,494.00 | 98,820.00 | 6.27 |
| 21 | 000219 | 博时裕益混合 | 9,182,582.50 | 72,475.00 | 4.65 |
| 22 | 519959 | 长信多利混合 | 6,488,940.50 | 51,215.00 | 6.98 |
| 23 | 001056 | 北信瑞丰健康生活主题灵活配置混合 | 5,435,430.00 | 42,900.00 | 4.94 |
| 24 | 510660 | 华夏医药ETF | 2,179,620.10 | 17,203.00 | 2.10 |
| 25 | 519987 | 长信恒利优势混合 | 1,410,931.20 | 11,136.00 | 6.40 |
| 26 | 000051 | 华夏沪深300ETF联接A | 182,448.00 | 1,440.00 | 0.00 |
| 27 | 005658 | 华夏沪深300ETF联接C | 182,448.00 | 1,440.00 | 0.00 |
